Clinical TrialID 4839

Theobromine, Vascular Function and Intestinal apoA-I Production

NCT02209025

Cardiovascular Disease

Back to Browse

Relationship Network

Interactive first-hop connections across herbs, ingredients, formulas, targets, diseases, symptoms, syndromes, evidence, and monographs.

Click a node to open it in a new tab
Trial: 1Ingredient: 1Links: 1
Arranging relationship network...

Record Fields

Scalar fields from the final clinical_trial record.

Clinical Trial Id
4839
Evidence Id
4839
Core Evidence Id
4839
Source Clinical Trial Id
4814
Herb2 Clinical Trial Id
HBCT004814
Nct Id
NCT02209025
Title
Theobromine, Vascular Function and Intestinal apoA-I Production
Status
Completed
Phase
Study Result
No
Study Condition
Cardiovascular Disease
Study Type
Interventional
Study Design
Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: PREVENTION
Intervention
DIETARY_SUPPLEMENT: Theobromine|DIETARY_SUPPLEMENT: Placebo drink
Intervention Allocation
Randomized
Intervention Model
Crossover
Intervention Mask
Quadruple
Intervention Purpose
Prevention
Gender
All
Age
Adult, Older_Adult
Enrollment
48
Outcome Measure
Flow mediated dilation, FMD measurements after 4 weeks of intake. Fasting and postprandial measurements, 4 weeks|Intestinal apoA-I production, Intestinal biopsies after 4 weeks of intake to see changes in apoA-I gene expression, After 4 weeks of intake
Sponsor Collaborator
Maastricht University Medical Center|Unilever R&D|DSM Nutritional Products, Inc.
Funded By
OTHER
Location
Maastricht University Hospital, Maastricht, 6200 MD, Netherlands
Other Id
NL46131.068.13/METC 13-3-065
Start Date
2014-06
Primary Completion Date
2015-09
Completion Date
2015-09
First Posted
2014-08-05
Results First Posted
Last Update Posted
2015-09-07
Study Document
Study Url
https://clinicaltrials.gov/study/NCT02209025
Title Cn
Title En
Theobromine, Vascular Function and Intestinal apoA-I Production
Bilingual Status
semi_complete